Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Liver Diseases

  Free Subscription


12 Am J Gastroenterol
2 Biochem Biophys Res Commun
3 BMC Cancer
1 BMC Gastroenterol
1 Dig Dis Sci
1 Endoscopy
2 Eur J Pediatr
7 Eur Radiol
1 Gastroenterology
15 Hepatology
1 J Gastroenterol Hepatol
1 J Hepatol
2 J Pediatr Surg
1 N Engl J Med
1 Oncogene
3 PLoS One
2 Semin Liver Dis
1 Transplant Proc
2 Transplantation

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Gastroenterol

  1. ZHAI LL, Tang ZG
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.

  2. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
    Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
    PubMed         Abstract available

  3. BJORNSSON HK, Bjornsson ES
    Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
    Am J Gastroenterol. 2021;116:1090-1091.

  4. BENMASSAOUD A, Tsochatzis E
    Response to Anand and Sharma.
    Am J Gastroenterol. 2021;116:1094-1095.

  5. KOK B, McNeely M, Watt M, Tandon P, et al
    Exercise Only Works If You Do It! The Holy Grail of Adherence.
    Am J Gastroenterol. 2021;116:673-674.
    PubMed         Abstract available

  6. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
    Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Am J Gastroenterol. 2021;116:733-740.
    PubMed         Abstract available

  7. ALUKAL JJ, Thuluvath PJ
    Reply to Morton.
    Am J Gastroenterol. 2021;116:835-836.

    Finding Common Ground With Our MASQs Off.
    Am J Gastroenterol. 2021;116:837.

  9. DEBNATH P, Rathi P
    Sarcopenia and TIPS: How Best to Measure Muscle Mass.
    Am J Gastroenterol. 2021;116:1358.

  10. BENMASSAOUD A, Tsochatzis E
    Response to Debnath and Rathi.
    Am J Gastroenterol. 2021;116:1358-1359.

  11. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
    Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
    Am J Gastroenterol. 2021;116:1360-1361.

  12. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
    Response to Ianiro et al.
    Am J Gastroenterol. 2021;116:1361-1362.

    Biochem Biophys Res Commun

  13. LIU C, Huang XY, Huang Y
    FAM83G promotes proliferation, invasion, and metastasis by regulating PI3K/AKT signaling in hepatocellular carcinoma cells.
    Biochem Biophys Res Commun. 2021;567:63-71.
    PubMed         Abstract available

  14. ZHANG H, Yao W, Zhang M, Lu Y, et al
    TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.
    Biochem Biophys Res Commun. 2021;550:84-91.
    PubMed         Abstract available

    BMC Cancer

  15. DAKURAH OB, Tamandjou CRT, Zunza M, Preiser W, et al
    Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review.
    BMC Cancer. 2021;21:715.
    PubMed         Abstract available

  16. HONG L, Zhou Y, Xie X, Wu W, et al
    A stemness-based eleven-gene signature correlates with the clinical outcome of hepatocellular carcinoma.
    BMC Cancer. 2021;21:716.
    PubMed         Abstract available

  17. XU H, Lan Q, Huang Y, Zhang Y, et al
    The mechanisms of colorectal cancer cell mesenchymal-epithelial transition induced by hepatocyte exosome-derived miR-203a-3p.
    BMC Cancer. 2021;21:718.
    PubMed         Abstract available

    BMC Gastroenterol

  18. WU ZH, Huang HM, Yang DL
    Integrated analysis of the functions and prognostic values of RNA binding proteins in hepatocellular carcinoma.
    BMC Gastroenterol. 2021;21:265.
    PubMed         Abstract available

    Dig Dis Sci

  19. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    PubMed         Abstract available


  20. UCHIMA H, Ble M, Busquets D, Serra I, et al
    Eradication of neoplastic Barrett's esophagus in patients with esophageal varices with a modified endoscopic mucosal resection technique and radiofrequency ablation.
    Endoscopy. 2021 Jun 18. doi: 10.1055/a-1516-3400.

    Eur J Pediatr

  21. TEUFEL-SCHAFER U, Flechtenmacher C, Fichtner A, Hoffmann GF, et al
    Transient elastography correlated to four different histological fibrosis scores in children with liver disease.
    Eur J Pediatr. 2021;180:2237-2244.
    PubMed         Abstract available

  22. EL AMROUSY D, El Ashry H, Maher S, Ganna S, et al
    Pulmonary function test abnormalities in children and adolescents with non-alcoholic fatty liver disease.
    Eur J Pediatr. 2021;180:1693-1699.
    PubMed         Abstract available

    Eur Radiol

  23. GUPTA P, Maralakunte M, Kumar-M P, Chandel K, et al
    Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Eur Radiol. 2021;31:5400-5408.
    PubMed         Abstract available

  24. PARK JH, Seo N, Chung YE, Kim SU, et al
    Noninvasive evaluation of liver fibrosis: comparison of the stretched exponential diffusion-weighted model to other diffusion-weighted MRI models and transient elastography.
    Eur Radiol. 2021;31:4813-4823.
    PubMed         Abstract available

  25. MAO B, Ma J, Duan S, Xia Y, et al
    Preoperative classification of primary and metastatic liver cancer via machine learning-based ultrasound radiomics.
    Eur Radiol. 2021;31:4576-4586.
    PubMed         Abstract available

  26. HUANG M, Shen S, Cai H, Peng Z, et al
    Regional liver function analysis with gadoxetic acid-enhanced MRI and virtual hepatectomy: prediction of postoperative short-term outcomes for HCC.
    Eur Radiol. 2021;31:4720-4730.
    PubMed         Abstract available

  27. HASENSTAB K, Cunha GM, Ichikawa S, Dehkordy SF, et al
    CNN color-coded difference maps accurately display longitudinal changes in liver MRI-PDFF.
    Eur Radiol. 2021;31:5041-5049.
    PubMed         Abstract available

  28. NAJAFI A, de Baere T, Purenne E, Bayar A, et al
    Risk factors for local tumor progression after RFA of pulmonary metastases: a matched case-control study.
    Eur Radiol. 2021;31:5361-5369.
    PubMed         Abstract available

  29. YOUN SY, Kim DH, Choi SH, Kim B, et al
    Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis.
    Eur Radiol. 2021;31:4785-4793.
    PubMed         Abstract available


  30. ACHARYA C, Bajaj JS
    Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease.
    Gastroenterology. 2021;160:556-572.
    PubMed         Abstract available


  31. NORTHUP PG, Garcia-Pagan JC, Garcia-Tsao G, Intagliata NM, et al
    Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021;73:366-413.

  32. JEPSEN P, Tapper EB, Deleuran T, Kazankov K, et al
    Risk and outcome of venous and arterial thrombosis in patients with cirrhosis: a Danish nationwide cohort study.
    Hepatology. 2021 Jun 16. doi: 10.1002/hep.32019.
    PubMed         Abstract available

  33. MUHAMMAD KHAN M, Alejandra Luna-Cuadros M, Lau DTY, Sehrawat TS, et al
    Hepatology Highlights.
    Hepatology. 2021;73:2085-2088.

  34. LIU H, Lee SS
    Diagnostic criteria of cirrhotic cardiomyopathy: out with the old, in with the new?
    Hepatology. 2021 Jun 21. doi: 10.1002/hep.32021.
    PubMed         Abstract available

  35. TORRENS L, Montironi C, Puigvehi M, Mesropian A, et al
    Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma.
    Hepatology. 2021 Jun 22. doi: 10.1002/hep.32023.
    PubMed         Abstract available

  36. CHOLANKERIL G, Kanwal F
    Nonalcoholic fatty liver disease and Hepatocellular Carcinoma: Time to Bridge the Gap.
    Hepatology. 2021 Jun 23. doi: 10.1002/hep.32025.
    PubMed         Abstract available

  37. CABALLERO-CAMINO FJ, Rivilla I, Herraez E, Briz O, et al
    Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease.
    Hepatology. 2021;73:186-203.
    PubMed         Abstract available

  38. ZHOU B, Liu C, Xu L, Yuan Y, et al
    N(6) -Methyladenosine Reader Protein YT521-B Homology Domain-Containing 2 Suppresses Liver Steatosis by Regulation of mRNA Stability of Lipogenic Genes.
    Hepatology. 2021;73:91-103.
    PubMed         Abstract available

  39. GU L, Zhu Y, Lin X, Lu B, et al
    The IKKbeta-USP30-ACLY Axis Controls Lipogenesis and Tumorigenesis.
    Hepatology. 2021;73:160-174.
    PubMed         Abstract available

  40. SARKAR M, Brady CW, Fleckenstein J, Forde KA, et al
    Reproductive Health and Liver Disease: Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021;73:318-365.

  41. ABUD A, Maddur H, Salem R
    Management of symptomatic portal cavernoma cholangiopathy via transplenic portal vein recanalization and TIPS.
    Hepatology. 2020 Jun 5. doi: 10.1002/hep.31411.
    PubMed         Abstract available

  42. DE JONGHE S, Weinstock D, Aligo J, Washington K, et al
    Biopsy Pathology and Immunohistochemistry of a Case of Immune-Mediated Drug-Induced Liver Injury With Atabecestat.
    Hepatology. 2021;73:452-455.

  43. LEONIS MA, Miethke AG, Fei L, Maynor S, et al
    Four Biomarkers Linked to Activation of Cluster of Differentiation 8-Positive Lymphocytes Predict Clinical Outcomes in Pediatric Acute Liver Failure.
    Hepatology. 2021;73:233-246.
    PubMed         Abstract available

  44. LI YJ, Phillips EJ, Dellinger A, Nicoletti P, et al
    Human Leukocyte Antigen B*14:01 and B*35:01 Are Associated With Trimethoprim-Sulfamethoxazole Induced Liver Injury.
    Hepatology. 2021;73:268-281.
    PubMed         Abstract available

  45. MORENO E, Toussaint MJM, van Essen SC, Bongiovanni L, et al
    E2F7 Is a Potent Inhibitor of Liver Tumor Growth in Adult Mice.
    Hepatology. 2021;73:303-317.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  46. HO SY, Liu PH, Hsu CY, Ko CC, et al
    Tumor burden score as a new prognostic marker for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    J Gastroenterol Hepatol. 2021 Jun 22. doi: 10.1111/jgh.15593.
    PubMed         Abstract available

    J Hepatol

  47. D'AMICO G, Bernardi M, Angeli P
    J Hepatol. 2021 Jun 19. pii: S0168-8278(21)00438.
    PubMed         Abstract available

    J Pediatr Surg

  48. WANG N, Wang J, Zhang T, Huang L, et al
    Alterations of gut microbiota and serum bile acids are associated with parenteral nutrition-associated liver disease.
    J Pediatr Surg. 2020 Jun 27. pii: S0022-3468(20)30463.
    PubMed         Abstract available

  49. MURAWSKI M, Losin M, Golebiewski A, Sinacka K, et al
    Laparoscopic resection of liver tumors in children.
    J Pediatr Surg. 2021;56:420-423.
    PubMed         Abstract available

    N Engl J Med

  50. BAJAJ JS, Kamath PS, Reddy KR
    The Evolving Challenge of Infections in Cirrhosis.
    N Engl J Med. 2021;384:2317-2330.


  51. LIN YH, Wu MH, Liu YC, Lyu PC, et al
    LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing.
    Oncogene. 2021 Jun 17. pii: 10.1038/s41388-021-01905.
    PubMed         Abstract available

    PLoS One

  52. LIN X, You F, Liu H, Fang Y, et al
    Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0245921.
    PubMed         Abstract available

  53. CHO Y, Lee S, Park SJ
    Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
    PLoS One. 2021;16:e0245911.
    PubMed         Abstract available

  54. CHENG K, Liu W, You J, Shah S, et al
    Safety of laparoscopic pancreaticoduodenectomy in patients with liver cirrhosis using propensity score matching.
    PLoS One. 2021;16:e0246364.
    PubMed         Abstract available

    Semin Liver Dis

  55. HSU YC, Tseng CH, Huang YT, Yang HI, et al
    Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730924.
    PubMed         Abstract available

  56. BRESSON-HADNI S, Spahr L, Chappuis F
    Hepatic Alveolar Echinococcosis.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730925.
    PubMed         Abstract available

    Transplant Proc

  57. CHENG Y, Lan H, Chen Y, Jiang Y, et al
    Erratum to "Protective Effect of Retrograde Reperfusion Against Hepatic Autophagy Impairment in Rat Liver Transplantation" by Yuan Cheng, Haibin Lan, Yongtai Chen, Yi Jiang, Yongbiao Chen, Transplantation Proceedings, 2021, Vol 53, pages 443-449.
    Transplant Proc. 2021 Jun 18. pii: S0041-1345(21)00398.


  58. PATRONO D, Zanierato M, Avolio AW, Romagnoli R, et al
    Different Timing of Cholangiocyte and Hepatocyte Damage in Liver Preservation: Time to Implement Donor Interventions and New Preservation Techniques to Prevent Ischemic-type Biliary Lesions.
    Transplantation. 2021;105:e77-e78.

  59. LIU XB, Liu H, Liu J, Cheung AKL, et al
    Cytomegalovirus Latency Exacerbated small-for-size Liver Graft Injury through Activation of CCL19/CCR7 in Hepatic Stellate Cells.
    Transplantation. 2021 Jun 2. doi: 10.1097/TP.0000000000003846.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.